UroGen Pharma Ltd.

Historical 13F Holders

Symbol
URGN
CUSIP
M96088105
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 145 41.6 M $461 M
2024 Q4 142 37.8 M $402 M
2024 Q3 134 35.2 M $446 M
2024 Q2 124 40.1 M $673 M
2024 Q1 120 28.0 M $419 M
2023 Q4 112 22.0 M $330 M
2023 Q3 108 17.7 M $248 M
2023 Q2 92 13.3 M $138 M
2023 Q1 71 12.5 M $116 M
2022 Q4 70 13.1 M $116 M
2022 Q3 64 13.3 M $111 M
2022 Q2 66 13.4 M $109 M
2022 Q1 84 14.2 M $124 M
2021 Q4 79 14.8 M $141 M
2021 Q3 96 14.1 M $237 M
2021 Q2 86 14.1 M $215 M
2021 Q1 93 14.3 M $279 M
2020 Q4 88 14.6 M $262 M
2020 Q3 88 15.0 M $289 M
2020 Q2 95 14.7 M $382 M
2020 Q1 85 14.0 M $250 M
2019 Q4 92 14.3 M $477 M
2019 Q3 88 14.6 M $347 M
2019 Q2 92 14.7 M $527 M
2019 Q1 78 13.5 M $497 M
2018 Q4 66 9.59 M $413 M
2018 Q3 75 9.95 M $470 M
2018 Q2 61 9.61 M $483 M
2018 Q1 44 9.17 M $456 M
2017 Q4 41 6.84 M $254 M
2017 Q3 32 4.61 M $145 M
2017 Q2 21 4.72 M $85.2 M